{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:10:57Z","timestamp":1790655057899,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.hbpd.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T21:49:15Z","timestamp":1630014555000},"page":"267-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Wen-Yan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-You","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2021.08.006_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2018.01.01","article-title":"Cancer incidence and mortality in China, 2014","volume":"30","author":"Chen","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0002","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/s10434-013-3292-z","article-title":"Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma","volume":"21","author":"Wu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/967472","article-title":"Gallbladder cancer in the 21st century","volume":"2015","author":"Kanthan","year":"2015","journal-title":"J Oncol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0004","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0005","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/cas.14102","article-title":"BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo","volume":"110","author":"Liu","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0006","doi-asserted-by":"crossref","first-page":"e2868","DOI":"10.1038\/cddis.2017.263","article-title":"EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0007","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0008","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0009","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0010","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0011","first-page":"245","article-title":"The inflammatory inception of gallbladder cancer","volume":"1865","author":"Espinoza","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/983698","article-title":"Neutrophils in cancer: two sides of the same coin","volume":"2015","author":"Uribe-Querol","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0013","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.18632\/oncotarget.23510","article-title":"Combined use of preoperative lymphocyte counts and the post\/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer","volume":"9","author":"Shinji","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0014","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12029-013-9491-9","article-title":"Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients","volume":"44","author":"Wan","year":"2013","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143080","article-title":"C-reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors: a systematic review","volume":"10","author":"Shrotriya","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr J"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0017","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.21873\/anticanres.11248","article-title":"Clinical burden of C-reactive protein\/albumin ratio before curative surgery for patients with gastric cancer","volume":"36","author":"Toiyama","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0018","doi-asserted-by":"crossref","first-page":"68837","DOI":"10.18632\/oncotarget.18575","article-title":"The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0019","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SLA.0000000000003239","article-title":"Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer","volume":"272","author":"Okugawa","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0020","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.3748\/wjg.v21.i21.6675","article-title":"Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma","volume":"21","author":"Pang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0021","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.hpb.2016.03.608","article-title":"Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma","volume":"18","author":"Zhang","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0022","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41598-018-38396-4","article-title":"Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer","volume":"9","author":"Zhu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0023","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0024","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/13651820701774891","article-title":"Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma","volume":"9","author":"Clark","year":"2007","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0026","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2008.19.8440","article-title":"Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer","volume":"27","author":"Allin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202555","article-title":"Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors","volume":"13","author":"Shrotriya","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0028","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1186\/s12885-016-2827-7","article-title":"Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels","volume":"16","author":"Lin","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0029","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/IGC.0b013e31828f7a24","article-title":"CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer","volume":"23","author":"Chen","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0030","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.3802\/jgo.2017.28.e7","article-title":"Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer","volume":"28","author":"Zwakman","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0031","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.18632\/oncotarget.6819","article-title":"Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2021.08.006_bib0032","doi-asserted-by":"crossref","first-page":"35423","DOI":"10.18632\/oncotarget.8770","article-title":"Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:42:59Z","timestamp":1761493379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387221001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1499387221001624"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.08.006","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}